Cargando…

Cannabinoid Receptor 1 Agonist ACEA and Cannabinoid Receptor 2 Agonist GW833972A Attenuates Cell-Mediated Immunity by Different Biological Mechanisms

Cannabinoid receptor 1 (CB1) and cannabinoid receptor 2 (CB2) are components in the endocannabinoid system that play significant roles in regulating immune responses. There are many agonists for the cannabinoid receptors; however, their effects on T cell regulation have not been elucidated. In the p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takheaw, Nuchjira, Jindaphun, Kanyaruck, Pata, Supansa, Laopajon, Witida, Kasinrerk, Watchara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047765/ https://www.ncbi.nlm.nih.gov/pubmed/36980189 http://dx.doi.org/10.3390/cells12060848

Ejemplares similares

Interaction of CD99 and its ligand upregulates IL-6 and TNF-α upon T cell activation
por: Takheaw, Nuchjira, et al.
Publicado: (2019)

The presence of membrane bound CD99 ligands on leukocyte surface
por: Takheaw, Nuchjira, et al.
Publicado: (2020)

Ligation of Na, K ATPase β3 subunit on monocytes by a specific monoclonal antibody mediates T cell hypofunction
por: Takheaw, Nuchjira, et al.
Publicado: (2018)

Differential CD147 Functional Epitopes on Distinct Leukocyte Subsets
por: Pata, Supansa, et al.
Publicado: (2021)

Association of CD99 short and long forms with MHC class I, MHC class II and tetraspanin CD81 and recruitment into immunological synapses
por: Pata, Supansa, et al.
Publicado: (2011)

Production of Monoclonal Antibodies against Human Trefoil Factor 3 and Development of a Modified-Sandwich ELISA for Detection of Trefoil Factor 3 Homodimer in Saliva
por: Khummuang, Saichit, et al.
Publicado: (2017)

Effects of the cannabinoid CB(1) agonist ACEA on salicylate ototoxicity, hyperacusis and tinnitus in guinea pigs
por: Berger, Joel I., et al.
Publicado: (2017)

Neutralizing antibody and T cell responses against SARS-CoV-2 variants of concern following ChAdOx-1 or BNT162b2 boosting in the elderly previously immunized with CoronaVac vaccine
por: Liwsrisakun, Chalerm, et al.
Publicado: (2022)

Correlation Analysis of Anti-SARS-CoV-2 RBD IgG and Neutralizing Antibody against SARS-CoV-2 Omicron Variants after Vaccination
por: Takheaw, Nuchjira, et al.
Publicado: (2022)

Levels and durability of neutralizing antibodies against SARS-CoV-2 Omicron and other variants after ChAdOx-1 or BNT162b2 booster in CoronaVac-primed elderly individuals
por: Takheaw, Nuchjira, et al.
Publicado: (2023)

Cannabinoid CB1 receptor agonist ACEA alleviates brain ischemia/reperfusion injury via CB1–Drp1 pathway
por: Yang, Shuai, et al.
Publicado: (2020)

Immunostick Test for Detecting ζ-Globin Chains and Screening of the Southeast Asian α-Thalassemia 1 Deletion
por: Pata, Supansa, et al.
Publicado: (2019)

Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study
por: Chaiwong, Warawut, et al.
Publicado: (2022)

Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
por: Finlay, David B., et al.
Publicado: (2022)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB(2) receptor
por: Patel, Monica, et al.
Publicado: (2023)

Interaction of Synthetic Cannabinoid Receptor Agonists with Cannabinoid Receptor I: Insights into Activation Molecular Mechanism
por: Gavryushov, Sergei, et al.
Publicado: (2023)

Impact of the detection of ζ-globin chains and hemoglobin Bart’s using immunochromatographic strip tests for α(0)-thalassemia (--(SEA)) differential diagnosis
por: Pata, Supansa, et al.
Publicado: (2019)

Cannabinoid receptor subtype 2 (CB(2)R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells
por: Huang, Zebing, et al.
Publicado: (2016)

Assessment of select synthetic cannabinoid receptor agonist bias and selectivity between the type 1 and type 2 cannabinoid receptor
por: Zagzoog, Ayat, et al.
Publicado: (2021)

PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)

Synthetic Cannabinoid Receptor Agonists Detection Using Fluorescence Spectral Fingerprinting
por: May, Benedict, et al.
Publicado: (2019)

New Pyridone-Based Derivatives as Cannabinoid Receptor Type 2 Agonists
por: Faúndez-Parraguez, Manuel, et al.
Publicado: (2021)

Docking and Molecular Dynamic Investigations of Phenylspirodrimanes as Cannabinoid Receptor-2 Agonists
por: Omar, Abdelsattar M., et al.
Publicado: (2022)

Cannabinoid receptor agonist attenuates angiotensin II–induced enlargement and mitochondrial dysfunction in rat atrial cardiomyocytes
por: Altieri, Danielle I., et al.
Publicado: (2023)

Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex
por: Diez-Alarcia, Rebeca, et al.
Publicado: (2016)

Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists
por: Sachdev, Shivani, et al.
Publicado: (2020)

Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights
por: Malaca, Sara, et al.
Publicado: (2021)

Expression of cannabinoid 1 and, 2 receptors and the effects of cannabinoid 1 and, 2 receptor agonists on detrusor overactivity associated with bladder outlet obstruction in rats
por: Kim, Sung Dae, et al.
Publicado: (2017)

Cannabinoids: A New Group of Agonists of PPARs
por: Sun, Yan, et al.
Publicado: (2007)

Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction
por: Jeon, Posung, et al.
Publicado: (2011)

The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists
por: Fuchs, Alexander, et al.
Publicado: (2013)

Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
por: Presley, Chaela, et al.
Publicado: (2015)

Impact of the mouse estrus cycle on cannabinoid receptor agonist‐induced molecular and behavioral outcomes
por: Kim, Hye Ji J., et al.
Publicado: (2022)

Development of Cross-Reactive Antibodies for the Identification and Treatment of Synthetic Cannabinoid Receptor Agonist Toxicity
por: Worob, Adam, et al.
Publicado: (2022)

Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB(2) Receptor
por: Taylor, Lewis, et al.
Publicado: (2015)

Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats
por: Calik, Michael W., et al.
Publicado: (2016)

High hopes for cannabinoid agonists in the treatment of rheumatic diseases
por: Staunton, Caroline A, et al.
Publicado: (2014)

Ligand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists
por: Gianella-Borradori, Matteo, et al.
Publicado: (2015)

Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists
por: Pandey, Pankaj, et al.
Publicado: (2018)

Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain
por: Yuill, Matthew B, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t5sjvlf4hifdj35t02m1r13p9e